161 related articles for article (PubMed ID: 22801737)
1. Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma.
Malleo G; Tonsi A; Marchegiani G; Casarotto A; Paiella S; Butturini G; Salvia R; Bassi C
Langenbecks Arch Surg; 2013 Feb; 398(2):287-94. PubMed ID: 22801737
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes in patients with duodenal adenocarcinoma.
Lee SY; Lee JH; Hwang DW; Kim SC; Park KM; Lee YJ
ANZ J Surg; 2014 Dec; 84(12):970-5. PubMed ID: 23656271
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Factors and Clinical Characteristics of Patients with Primary Duodenal Adenocarcinoma: A Single-Center Experience from China.
Jiang QL; Huang XH; Chen YT; Zhang JW; Wang CF
Biomed Res Int; 2016; 2016():6491049. PubMed ID: 28116301
[No Abstract] [Full Text] [Related]
4. Clinicopathological analysis and survival outcome of duodenal adenocarcinoma.
Kim MJ; Choi SB; Han HJ; Park PJ; Kim WB; Song TJ; Suh SO; Choi SY
Kaohsiung J Med Sci; 2014 May; 30(5):254-9. PubMed ID: 24751389
[TBL] [Abstract][Full Text] [Related]
5. Duodenal gastrointestinal stromal tumor: clinicopathological characteristics, surgical outcomes, long term survival and predictors for adverse outcomes.
Yang F; Jin C; Du Z; Subedi S; Jiang Y; Li J; Di Y; Zhou Z; Tang F; Fu D
Am J Surg; 2013 Sep; 206(3):360-7. PubMed ID: 23673012
[TBL] [Abstract][Full Text] [Related]
6. Duodenal adenocarcinoma: Surgical results of 27 patients treated at a single center.
López-Domínguez J; Busquets J; Secanella L; Peláez N; Serrano T; Fabregat J
Cir Esp (Engl Ed); 2019 Nov; 97(9):523-530. PubMed ID: 31563268
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of the posterior resection margin for predicting disease free survival in ampullary adenocarcinoma.
Schneider C; Sodergren MH; Pencavel T; Soggiu F; Bhogal RH; Khan AZ
Surg Oncol; 2020 Dec; 35():211-217. PubMed ID: 32911213
[TBL] [Abstract][Full Text] [Related]
8. Surgical outcomes for duodenal adenoma and adenocarcinoma: a multicentre study in Australia and the United Kingdom.
Lee CHA; Shingler G; Mowbray NG; Al-Sarireh B; Evans P; Smith M; Usatoff V; Pilgrim C
ANZ J Surg; 2018 Mar; 88(3):E157-E161. PubMed ID: 28122405
[TBL] [Abstract][Full Text] [Related]
9. Primary duodenal adenocarcinoma: a ten-year experience with 79 patients.
Rose DM; Hochwald SN; Klimstra DS; Brennan MF
J Am Coll Surg; 1996 Aug; 183(2):89-96. PubMed ID: 8696551
[TBL] [Abstract][Full Text] [Related]
10. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas.
Wang SE; Shyr YM; Su CH; Chen TH; Wu CW
Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381
[TBL] [Abstract][Full Text] [Related]
11. Superior prognostic importance of perineural invasion vs. lymph node involvement after curative resection of duodenal adenocarcinoma.
Cecchini S; Correa-Gallego C; Desphande V; Ligorio M; Dursun A; Wargo J; Fernàndez-del Castillo C; Warshaw AL; Ferrone CR
J Gastrointest Surg; 2012 Jan; 16(1):113-20; discussion 120. PubMed ID: 22005894
[TBL] [Abstract][Full Text] [Related]
12. Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma.
Mann K; Gilbert T; Cicconi S; Jackson R; Whelan P; Campbell F; Halloran C; Neoptolemos J; Ghaneh P
Langenbecks Arch Surg; 2019 Jun; 404(4):439-449. PubMed ID: 30972486
[TBL] [Abstract][Full Text] [Related]
13. Outcome after surgical resection for duodenal adenocarcinoma in the UK.
Solaini L; Jamieson NB; Metcalfe M; Abu Hilal M; Soonawalla Z; Davidson BR; McKay C; Kocher HM;
Br J Surg; 2015 May; 102(6):676-81. PubMed ID: 25776995
[TBL] [Abstract][Full Text] [Related]
14. What prognostic factors are important in duodenal adenocarcinoma?
Bakaeen FG; Murr MM; Sarr MG; Thompson GB; Farnell MB; Nagorney DM; Farley DR; van Heerden JA; Wiersema LM; Schleck CD; Donohue JH
Arch Surg; 2000 Jun; 135(6):635-41; discussion 641-2. PubMed ID: 10843358
[TBL] [Abstract][Full Text] [Related]
15. Pancreaticoduodenectomy for nonampullary duodenal lesions: indications and results.
Shamali A; McCrudden R; Bhandari P; Shek F; Barnett E; Bateman A; Abu Hilal M
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1388-1393. PubMed ID: 27603299
[TBL] [Abstract][Full Text] [Related]
16. Adenocarcinoma of the duodenum: factors influencing long-term survival.
Sohn TA; Lillemoe KD; Cameron JL; Pitt HA; Kaufman HS; Hruban RH; Yeo CJ
J Gastrointest Surg; 1998; 2(1):79-87. PubMed ID: 9841972
[TBL] [Abstract][Full Text] [Related]
17. Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment.
Poultsides GA; Huang LC; Cameron JL; Tuli R; Lan L; Hruban RH; Pawlik TM; Herman JM; Edil BH; Ahuja N; Choti MA; Wolfgang CL; Schulick RD
Ann Surg Oncol; 2012 Jun; 19(6):1928-35. PubMed ID: 22167476
[TBL] [Abstract][Full Text] [Related]
18. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.
Sohn TA; Yeo CJ; Cameron JL; Koniaris L; Kaushal S; Abrams RA; Sauter PK; Coleman J; Hruban RH; Lillemoe KD
J Gastrointest Surg; 2000; 4(6):567-79. PubMed ID: 11307091
[TBL] [Abstract][Full Text] [Related]
19. [A result of surgical treatment for ductal adenocarcinoma of the head of the pancreas].
Moon HJ; Jang KT; Heo JS; Choi SH; Joh JW; Kim YI
Korean J Gastroenterol; 2003 Aug; 42(2):156-63. PubMed ID: 14532721
[TBL] [Abstract][Full Text] [Related]
20. Extent of resection in the management of duodenal adenocarcinoma.
Kaklamanos IG; Bathe OF; Franceschi D; Camarda C; Levi J; Livingstone AS
Am J Surg; 2000 Jan; 179(1):37-41. PubMed ID: 10737576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
